Albany, NY (PRWEB) September 27, 2013
Chinese Digital Home, Home Networking Policies, and Industry Standard Development
With broadband networks and related technologies maturing, and following promotion of the government's tri-network convergence policies, digital home and home networking development for regular households in China has been accelerating in the period covered by the country's 11th and 12th five-year plans. Standard alliances set up by the Chinese home electronics and IT industries, such as IGRS and ITopHome, have gradually developed a comprehensive set of national standards for home networking in China.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/chinese-digital-home-home-networking-policies-and-industry-standard-development
Meanwhile, telecom operators including China Telecom and China Unicom have started to promote smart home services targeting high-income households. This report analyzes current digital home policies in China and the development of smart home industry standards.
Table of Contents
1. Development of The Digital Home and Home Networking in China
1.1 Industry Development
1.2 Human Resources Cultivation
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/175704
2. Strategies for China\'s Digital TV and Digital Home Industries in the 12th Five-year Plan
2.1 Industry Structure
2.2 Industry Clusters
2.3 Standards Developed by China
2.4 Industry Cooperation
2.5 Trial Projects
3. Standard Development in China\'s Home Networking Industry
3.1.1 IGRS Smart Home Solutions
3.3.1 Current Market Status of the WAPI Standard
Table 1 Digital Home Technology Standards Announced by China
Table 2 Digital Home Technology Standards Currently Being Developed by China
Figure 1 Scale of China\'s Digital Home Industry, 2008 - 2015
Figure 2 The Digital Home in China\'s 12th Five-year Plan
Figure 3 Government Agencies Involved in Digital Home Development
Figure 4 IGRS Smart Home Solutions
Figure 5 Key Members of the ITopHome Alliance
Hysterectomy Alternatives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hysterectomy-alternatives-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Hysterectomy is the process where complete or partial uterus is removed from the women’s body by the gynecologist. In complete uterus removal, fundus, cervix and body of the uterus are removed whereas in partial only body of the uterus is excised.Hysterectomy is performed when a women is suffering from fibroids, uterine prolapse, endometriosis, chronic pelvic pain, vaginal bleeding and cancer of uterus, ovaries and cervix. It has been observed in U.S. that 1 out of 3 women are undergoing hysterectomy annually. Hysterectomy has various issues such as hormonal imbalance, inability to conceive and disappearance of menstruation. To overcome these problems various alternative methods are currently being adopted by the gynecologist. These alternatives include myomectomy, uterine artery embolization (UAE), hysteroscopy, endometrial ablation and hormonal treatments.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/174042
Myomectomy is the process of removal of fibroids without altering or removing any part of the uterus. Uterine artery embolization is the process of injecting small particles such as PVA (poly vinyl alcohol) in the uterus which would stop the supply of blood to the fibroids and thus stops its growth. In hysteroscopy, a small thin instrument is inserted in the uterus through vagina to carve out the fibroids. With the help medical management various drugs are prescribed and device is implanted to treat different uterine problems. These drugs include Mortin and oral contraceptives whereas devices include intrauterine devices. In endometrial ablation, with the use of laser light infected cells of uterus are killed and hence relieves from infection and pain while in hormonal treatment, various hormones are injected in the body to inhibit the actions of the infected cell.
Incretion Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/incretion-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Incretion is a process of internal secretion of hormone through endocrine glands. These hormones control the major internal body functions such as digestive activities and movement. Sometimes these hormones are not secreted in an appropriate amount to control internal body functions. When such situation arises, a patient is advised for intake of incretion drugs. These incretion drugs stimulate secretion of various endocrine hormones as per the body requirement.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/174041
Prescription of an incretion drug varies as per the disease condition. A patient may suffer from endocrinal disorders such as diabetes; thyroid and infertility for which incretion drugs could be prescribed. In addition, these drugs could also be prescribed when pituitary and adrenal glands fail to secrete hormones in appropriate amount. Various incretion drugs include Orinase (tolbutamide), Amaryl (gimepiride), Glucotrol XL (glipizide), Glucotrol (glipizide), Micronase (glyburide), DiaBeta (glyburide), Glynase PresTab (glyburide, micronized), Prandin (repaglinide) and Starlix (nateglinide). Other incretion drugs are Januvia, Onglyza, Tradjenta, Glucovance, Metaglip, ActoPlus Met, Avandamet, Duetact, Avandryl, PrandiMet, Janumet, PrandiMet, ActoPlus Met XR and Kombiglyze XR.
MarketResearchReports. Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948